PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
128.32%
Net income growth above 1.5x CSIQ's 16.12%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
18.05%
D&A growth of 18.05% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
395.60%
Deferred tax of 395.60% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
63.76%
Less SBC growth vs. CSIQ's 281.50%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-207.91%
Negative yoy working capital usage while CSIQ is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-801.27%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
55.84%
Inventory growth of 55.84% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
62.45%
AP growth of 62.45% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-1072.33%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
42.80%
Some yoy increase while CSIQ is negative at -28.28%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
93.62%
CFO growth of 93.62% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
67.09%
CapEx growth of 67.09% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
328.08%
Acquisition growth of 328.08% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-48.14%
We reduce yoy other investing while CSIQ is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-64.49%
We reduce yoy invests while CSIQ stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
975.10%
Debt repayment growth of 975.10% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
-210.96%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.